Camurus AB (publ) (CAMX.ST)
Develops injectable medicines for opioid addiction, chronic pain, and rare diseases.
625.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago-6.6%
The outlook
CAMX.ST is trading at 625 SEK, positioned solidly above both its 50- and 200-day moving averages and roughly midway through its 52-week range. Analyst consensus leans Strong Buy, with the average price target implying roughly 24% upside from current levels. The stock commands a relatively high trailing P/E of 55.4, reflecting elevated market expectations.
What’s behind the score
Analyst consensusStrong Buy — 1.1 avg of 8 analysts
Price trendAbove its 50- & 200-day averages
52-week range60% of the way from its 52-week low to high
Price targetAvg target +24% vs current price
Analyst price target
~12-month · 8 analysts776.75average target+24.3% vs now
Now 625.00
Low 650.00High 914.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$37.19B
52-wk high
754.50
52-wk low
430.80
50-day avg
555.51
200-day avg
571.41
Trailing P/E
55.4